Global Point of Care (POC) Infectious Disease Diagnostic Testing Market Report 2018: Focus on Influenza, STD, HIV, Hepatitis, Malaria, C. difficile, E. coli, H. pylori & Home Test/OTC

NEXT STORY
BeyondSpring Presents Lead Asset’s Mechanism Data for Prevention of Chemotherapy-Induced Neutropenia
PREV STORY
Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ascendis Pharma A/S Announces Year-End 2017 Financial Results and Business Update Conference Call on March 28

COPENHAGEN, Denmark, March 16, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical ...

author_avatar
NASDAQ Market News

ArriVent Biopharma Launches with Up To $150M in Series A Financing and Strategic Licensing Agreement for Clinical-Stage Oncology Asset

author_avatar
NASDAQ Market News

Amolyt Pharma Announces Hiring of Louis J. Arcudi III as Chief Financial Officer

author_avatar
NASDAQ Market News